Phase 1 Clinical Trials, Alexandria, VA, USA
Event Sep 29
Carrying out an efficient, safe and compliant Phase I trial is necessary for drug development, however it is not sufficient. During the Preclinical and Phase I stages of early development lies the opportunity to assess and predict whether the drug is biologically plausible. The ability to manage and execute a Phase I study, while remaining cognizant of efficacy factors for Phase II will distinguish a successful Phase I clinical trial. This workshop explores the techniques and strategy for mastering this challenge.